跳至主要内容
临床试验/NCT06577155
NCT06577155已完成2 期

The Effect of Nalbuphine as an Adjuvant to Levobupivacaine in Subarachnoid Anesthesia in Total Hip Arthroplasty. A Double-blind, Randomized, Controlled Study.

Asklepieion Voulas General Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
Morphine consumption

研究概览

简要总结

60 patients ASA I-III, undergoing total hip arthroplasty were randomly assigned, into one of two groups, namely group E (n=30), where levobupivacaine will be administeral intrathecally ; and group N (n=30), where levobupivacaine plus nalbuphine will be administeral intrathecally. All patients will receive a standardized multimodal analgesic regimen, including a PENG block and PCA morphine. Morphine consumption during the first 24 hours postoperatively will be measured and additionally the investigators will record: Time of morphine first dose administration, NRS scores in static and dynamic conditions in 4 hours, 6 hours, 12 hours, 18 hours, 24 hours, 36 hours and 48 hours postoperatively, complications, patient satisfaction and duration of hospitalization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physical status according to American Society of Anesthesiologists (ASA) I-III
  • Patients scheduled for total hip arthroplasty

排除标准

  • BMI above 40
  • Serious psychiatric, mental and cognitive disorders
  • Contraindication for central and/or peripheral nervous blockade
  • History of allergic or other adverse reactions on the agents used in the study
  • Chronic opioid

研究组 & 干预措施

N

Active Comparator

Spinal levobupivacaine plus nalbuphine

干预措施: Levobupivacaine plus nalbuphine (Drug)

E

Active Comparator

Spinal levobupivacaine

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

Morphine consumption

时间窗: 24 hours

NRS scores

时间窗: 48 hours

次要结局

  • motor block onset(1 hour)
  • sensory block onset(1 hour)
  • sensory block level(1 hour)
  • motor block level(1 hour)
  • sensory block duration(4 hours)
  • motor block duration(4 hours)
  • Complications(24 hours)

研究者

发起方
Asklepieion Voulas General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Alexandros Makris

Consultant Anaesthesiologist

Asklepieion Voulas General Hospital

研究点 (2)

Loading locations...

相似试验